SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-019005
Filing Date
2020-03-13
Accepted
2020-03-13 17:41:46
Documents
2
Period of Report
2020-03-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5167
2 POA DOCUMENT poa.txt EX-24.4_904487 3793
  Complete submission text file 0001209191-20-019005.txt   10451
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Issuer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 509 WATERVIEW PLACE NEW HOPE PA 18938
Business Address
Zakrzewski Joseph S (Reporting) CIK: 0001331852 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30171 | Film No.: 20714248